严重脓毒症与脓毒性休克患者预后分析
Prognostic analysis of patients with severe sepsis and septic shock

DOI: 10.6040/j.issn.1671-7554.0.2015.957

Keywords: 严重脓毒症,脓毒性休克,分层分析,预后,
Stratified analysis,Severe sepsis,Septic shock,Prognosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2): 165-228.
[2]	Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis, 1987, 40(5): 373-383.
[3]	“D-二聚体检测”急诊临床应用专家共识组. “D-二聚体检测”急诊临床应用专家共识[J]. 中华急诊医学杂志, 2013, 22(8): 827-836.
[4]	Baharoon S, Telmesani A, Tamim H, et al. Community-versus nosocomial-acquired severe sepsis and septic shock in patients admitted to a tertiary intensive care in Saudi Arabia, etiology and outcome[J]. J Infect Public Health, 2015, 8(5): 418-424.
[5]	Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review[J]. Crit Care Med, 2010, 38(5): 1276-1283.
[6]	郑秀芹, 钟晓梅, 马建华, 等. 降钙素原结合APACHE-Ⅱ评分在老年重症感染患者中的诊断和预后意义[J]. 中国感染与化疗杂志, 2015, 15(1): 47-50. ZHENG Xiuqin, ZHONG Xiaomei, MA Jianhua, et al. Diagnostic and prognostic implication of procalcitonin combined with APACHE-Ⅱscore in elderly patients with severe infection[J]. Chin J Infect Chemother, 2015, 15(1): 47-50.
[7]	黄伟平, 江稳强, 胡北, 等. 降钙素原对全身炎症反应综合征患者病情预后的判断价值[J]. 中华危重病急救医学, 2012, 24(5): 294-297. HUANG Weiping, JIANG Wenqiang, HU Bei, et al. Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome[J]. Chin Crit Care Med, 2012, 24(5): 294-297.
[8]	Yang Y, Yang KS, Hsann YM, et al. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis[J]. J Crit Care, 2010, 25(3): 398-405.
[9]	Storgaard M, Hallas J, Gahrn-Hansen B, et al. Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock[J]. Scand J Infect Dis, 2013, 45(8): 577-583.
[10]	Lemay AC, Anzueto A, Restrepo MI, et al. Predictors of long-term mortality after severe sepsis in the elderly[J]. Am J Med Sci, 2014, 347(4): 282-288.
[11]	马晓春. 应重视脓毒症的抗凝治疗[J]. 中华危重病急救医学, 2010, 22(9): 516-517.
[12]	中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014)[J]. 中华危重病急救医学, 2015, 27(6): 401-426.
[13]	占志刚,李春盛. D-二聚体对急诊脓毒症患者预后价值的前瞻性研究[J]. 中华危重病急救医学,2012, 24(3): 135-138. ZHAN Zhigang, LI Chunsheng. Prognostic value of D-dimer in patients with sepsis in emergency department: a prospective study[J]. Chin Crit Care Med, 2012, 24(3): 135-138.
[14]	商娜,周荣斌. 脓毒症流行病学研究[J]. 中国急救医学, 2013, 33(1): 8-12. SHANG Na, ZHOU Rongbin. Research on the epidemiology of sepsis[J]. Chin J Crit Care Med, 2013, 33(1): 8-12.
[15]	Cawcutt KA, Peters SG. Severe sepsis and septic shock: clinical overview and update on management[J]. Mayo Clin Proc, 2014, 89(11): 1572-1578.
[16]	Rodríquez F, Barrera L, De La Rosa G, et al. The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals[J]. Crit Care Med, 2011, 39(7): 1675-1682.
[17]	Blanco J, Muriel-Bombín A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentrestudy[J]. Crit Care, 2008, 12(6): R158.

Full-Text